Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$82K Hold
233
0.01% 75
2025
Q4
$76.3K Hold
233
0.01% 77
2025
Q3
$65.8K Buy
+233
New +$67.6K ﹤0.01% 75
2023
Q4
Sell
-4,551
Closed -$1.22M 63
2023
Q3
$1.22M Sell
4,551
-25,811
-85% -$6.44M 0.12% 41
2023
Q2
$6.74M Hold
30,362
0.65% 21
2023
Q1
$7.34M Hold
30,362
0.77% 19
2022
Q4
$7.97M Hold
30,362
0.85% 18
2022
Q3
$6.84M Buy
30,362
+8,078
+36% +$1.96M 0.83% 17
2022
Q2
$5.42M Buy
22,284
+6,792
+44% +$1.66M 0.72% 20
2022
Q1
$3.75M Buy
15,492
+2,654
+21% +$610K 0.38% 26
2021
Q4
$2.89M Buy
+12,838
New +$2.71M 0.32% 28

Other funds holding AMGN

Hikari Tsushin Inc's AMGN Position: Q1 2026 in Review

Hikari Tsushin Inc held its Amgen (AMGN) position steady in Q1 2026 at 233 shares worth $82K. The position accounts for 0.01% of the portfolio, ranked #75.

Hikari Tsushin Inc first reported a position in AMGN in Q4 2021 and has held it in 11 quarters since. The position peaked at $7.97M in Q4 2022. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Hikari Tsushin Inc held 233 shares of Amgen worth $82K as of Q1 2026.
  • Hikari Tsushin Inc left its Amgen share count unchanged in Q1 2026.
  • Amgen made up 0.01% of Hikari Tsushin Inc's portfolio in Q1 2026, its #75 holding.
  • Hikari Tsushin Inc first reported a position in Amgen in Q4 2021 and has held it in 11 quarters since.
  • Hikari Tsushin Inc's Amgen position peaked at $7.97M in Q4 2022.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Hikari Tsushin Inc's 13F filing for Q1 2026, filed 13 May 2026.